Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers

Go back to Transgene Reports Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-Positive Cancers
Pfizer Inc. (NYSE: PFE) Delayed: 30.42 +0.57 (1.91%)
Previous Close $29.85    52 Week High $37.39 
Open $30.05    52 Week Low $28.25 
Day High $30.44    P/E 18.44 
Day Low $29.88    EPS $1.65 
Volume 27,519,966       

Puritan Financial Group, Inc. (AMEX: TNG) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.01 
Open $0.01    52 Week Low $0.01 
Day High $0.01    P/E N/A 
Day Low $0.01    EPS $0.00 
Volume 0